Showing 161 - 180 results of 237 for search '"pharmacodynamics"', query time: 0.04s Refine Results
  1. 161

    Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease by Yu. V. Yevsyutina

    Published 2018-08-01
    “…Pharmacokinetic and pharmacodynamic properties of the drug determined its ability to relief heartburn faster than other PPIs, to provide higher rate of erosion healing than omeprazole. …”
    Get full text
    Article
  2. 162

    GutBugDB: a web resource to predict the human gut microbiome-mediated biotransformation of biotic and xenobiotic molecules by Usha Longwani, Ashok K. Sharma, Aditya S. Malwe, Shubham K. Jaiswal, Vineet K. Sharma

    Published 2025-01-01
    “…There has been a growing recognition of the significant role played by the human gut microbiota in altering the bioavailability as well as the pharmacokinetic and pharmacodynamic aspects of orally ingested xenobiotic and biotic molecules. …”
    Get full text
    Article
  3. 163

    Low‐dimensional neural ordinary differential equations accounting for inter‐individual variability implemented in Monolix and NONMEM by Dominic Stefan Bräm, Bernhard Steiert, Marc Pfister, Britta Steffens, Gilbert Koch

    Published 2025-01-01
    “…The potential of such implementations is shown on various demonstrational datasets available in the Monolix model library, including pharmacokinetic (PK), pharmacodynamic (PD), target‐mediated drug disposition (TMDD), and survival analyses. …”
    Get full text
    Article
  4. 164

    Diosgenin: Recent Highlights on Pharmacology and Analytical Methodology by Mafalda Jesus, Ana P. J. Martins, Eugenia Gallardo, Samuel Silvestre

    Published 2016-01-01
    “…Due to its pharmacological and industrial importance, several extraction and analytical procedures have been developed and applied over the years to isolate, detect, and quantify diosgenin, not only in its natural sources and pharmaceutical compositions, but also in animal matrices for pharmacodynamic, pharmacokinetic, and toxicological studies. …”
    Get full text
    Article
  5. 165

    Grape Seed Procyanidin Extract Improves Insulin Production but Enhances Bax Protein Expression in Cafeteria-Treated Male Rats by Lídia Cedó, Anna Castell-Auví, Victor Pallarès, Mayte Blay, Anna Ardévol, Montserrat Pinent

    Published 2013-01-01
    “…Considering that pharmacokinetic and pharmacodynamic parameters in females are different from these parameters in males, the aim of the present study was to evaluate the effects of GSPE on male Wistar cafeteria-induced obese rats. …”
    Get full text
    Article
  6. 166

    Scorpion Venom and the Inflammatory Response by Vera L. Petricevich

    Published 2010-01-01
    “…Scorpion venoms consist of a complex of several toxins that exhibit a wide range of biological properties and actions, as well as chemical compositions, toxicity, and pharmacokinetic and pharmacodynamic characteristics. These venoms are associated with high morbility and mortality, especially among children. …”
    Get full text
    Article
  7. 167

    Therapeutic implications for the PD-1 axis in cerebrovascular injury by James Feghali, Christopher M. Jackson

    Published 2025-01-01
    “…Further investigation of PD-1 agonism as a therapeutic strategy in cerebrovascular injury can help clarify the mechanisms underlying clinical benefit, develop drugs with optimal pharmacodynamic and pharmacokinetic properties, and mitigate unwanted side effects.…”
    Get full text
    Article
  8. 168

    Effects of Breakpoint Changes on Carbapenem Susceptibility Rates ofEnterobacteriaceae: Results from the SENTRY Antimicrobial Surveillance Program, United States, 2008 to 2012 by Robert P Rennie, Ronald N Jones

    Published 2014-01-01
    “…This is based on patient response, pharmacokinetic/pharmacodynamic information and in vitro minimal inhibitory concentration data. …”
    Get full text
    Article
  9. 169

    Evaluation of the Cerebral State Index in Cats under Isoflurane Anaesthesia: Dose-Effect Relationship and Prediction of Clinical Signs by Joana R. Sousa, Lénio Ribeiro, Aura Silva, David A. Ferreira

    Published 2014-01-01
    “…The CSI, hemodynamic data, ocular reflexes, and eye position were recorded for each EtIso concentration. Pharmacodynamic analysis of CSI with EtIso was performed, as well as prediction probability analysis with a clinical scale based on the eye reflexes. …”
    Get full text
    Article
  10. 170
  11. 171

    PET in neurotherapeutic discovery and development by Melissa Chassé, Neil Vasdev

    Published 2025-01-01
    “…By incorporating such radionuclides into molecules of interest, we can directly assess their pharmacokinetic and pharmacodynamic (PK/PD) characteristics in vivo without changing their physicochemical characteristics or eliciting a pharmacological response. …”
    Get full text
    Article
  12. 172

    Effects of typical plant growth regulator chlormequat chloride on alkaloidal compounds in Corydalis yanhusuo and molecular mechanisms by Zixuan Du, Jiayin Cao, Jie Meng, Heng Zhou, Qing Hu, Ling Li, Yun Liao, Shui Miao, Wenting Li, Shen Ji, Tongshuai Wang

    Published 2025-01-01
    “…A comprehensive metabolomics evaluation method was developed that focuses on pharmacodynamically active compounds. Transcriptomic analysis also facilitates the identification of differential genes and enzymes associated with alkaloid production between the two groups. …”
    Get full text
    Article
  13. 173

    Partial AUCs in Long-Acting Injectables: Rationale, Challenges, Variability, Usefulness, and Clinical Relevance by Georgia Tsakiridou, Maria-Faidra-Galini Angelerou, Panagiotis Efentakis, Antonios Margaritis, Antigoni-Maria Papanastasiou, Lida Kalantzi

    Published 2024-12-01
    “…The choice of meaningful cut-off points in pAUC estimates can be especially difficult in the case of long-acting injectable (LAI) products, where long dosing intervals and complex pharmacokinetic (PK) and pharmacodynamic (PD) profiles apply, but most importantly, because there is not always a clear PK/PD relationship established. …”
    Get full text
    Article
  14. 174

    Novel Biologically Potent Diorganosilicon(IV) Complexes of Indole-2,3-Dione Derivatives by R. V. Singh, Pooja Nagpal

    Published 2005-01-01
    “…The aim of the present study is to synthesize some novel ecofriendly fungicides and bactericides of indole-2,3-dione derivatives, having important pharmacodynamic significance. The ligands used in the present account are derived by the condensation of 1,3-dihydro-3-[2-(phenyl)-2-oxoethylidene]-2H-indol-2- one, 1,3-dihydro-3-[2-(4-nitrophenyl)-2-oxoethylidene]-2H-indol-2-one and 1,3-dihydro-3-[2-(4-nitro-3-methylphenyl)- 2-oxoethylidene]-2H-indol-2-one with hydrazinecarboxamide and hydrazinecarbothioamide. …”
    Get full text
    Article
  15. 175

    Potential QT-prolonging drug-drug interactions in cardiovascular disease patients by Milena Kovačević, Milica Ćulafić, Marija Jovanović, Sandra Vezmar Kovačević, Katarina Vučićević, Branislava Miljković, Predrag Stevanović, Slavica Radovanović

    Published 2025-01-01
    “…The highest frequency was observed for ciprofloxacin (involved in 5 pDDIs), followed by propafenone (4 pDDIs) and beta2-agonists (4 pDDIs). The pharmacodynamic mechanism was involved in all pDDIs. The study revealed a low prevalence of QT-prolonging pDDIs on admission to the cardiology ward, about 3% in the studied population. …”
    Get full text
    Article
  16. 176

    Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndrome by Tunjungseto Arif, Iffatunnisa Fakhriyah, Pratiwi Intan Winta, Alif Azzam Muhyiddin Afrizal, Ahsan Fadhil, Santoso Budi

    Published 2025-01-01
    “…This study aimed to identify potential Indonesian phytoconstituents that inhibit PPARG both from a pharmacokinetic and pharmacodynamic perspective based on the in silico approach. …”
    Get full text
    Article
  17. 177

    Ginkgetin Alleviates Inflammation and Senescence by Targeting STING by Yadan Liu, Jialin Ye, Zisheng Fan, Xiaolong Wu, Yinghui Zhang, Ruirui Yang, Bing Jiang, Yajie Wang, Min Wu, Jingyi Zhou, Jingyi Meng, Zhiming Ge, Guizhen Zhou, Yuan Zhu, Yichuan Xiao, Mingyue Zheng, Sulin Zhang

    Published 2025-01-01
    “…Furthermore, in vivo pharmacodynamic data showed that Ginkgetin effectively alleviates systemic inflammation in Trex1−/− mice and inhibits the abnormally activated STING signaling in aging mouse model. …”
    Get full text
    Article
  18. 178

    PEPITEM, its tripeptide pharmacophores and their peptidomimetic analogues regulate the inflammatory response through parenteral and topical dosing in models of peritonitis and psor... by Anella Saviano, Bonita Apta, Samantha Tull, Laleh Pezhman, Areeba Fatima, Mustafa Sevim, Antonio Mete, Myriam Chimen, Anna Schettino, Noemi Marigliano, Helen M. McGettrick, Asif J. Iqbal, Francesco Maione, G. Ed Rainger

    Published 2025-03-01
    “…Here, we identify two independently active tripeptide pharmacophores within PEPITEM and engineered peptidomimetics with enhanced pharmacodynamic properties. These peptidomimetics regulate T-cell trafficking in vitro and reduce T-cell, neutrophil and macrophage numbers in the inflamed peritoneal cavity in vivo. …”
    Get full text
    Article
  19. 179

    Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy by Hicham Wahnou, Riad El Kebbaj, Bertrand Liagre, Vincent Sol, Youness Limami, Raphaël Emmanuel Duval

    Published 2025-01-01
    “…We discuss various NP formulations, including polymeric, lipid-based, and inorganic nanoparticles, highlighting their role in improving curcumin’s pharmacokinetic and pharmacodynamic profiles. The mechanisms by which CNPs exert anticancer effects, such as inducing apoptosis, inhibiting cell proliferation, and modulating signaling pathways, are explored in details. …”
    Get full text
    Article
  20. 180

    Our anaesthesia experiences and methods in burn patients by Bilge Tuncer, Ali Emre Akgun, Ugur Kilinc, Muge Cakirca, Merve Akin

    Published 2024-04-01
    “…It is imperative that anaesthetists are aware of the pharmacokinetic and pharmacodynamic changes that occur in burn patients, in order that they may determine the appropriate doses of the most suitable agents. …”
    Get full text
    Article